Found: 25
Select item for more details and to access through your institution.
Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 5, p. 848, doi. 10.1002/pon.5876
- By:
- Publication type:
- Article
Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub‐study of the French CANTO cohort.
- Published in:
- Psycho-Oncology, 2021, v. 30, n. 4, p. 463, doi. 10.1002/pon.5572
- By:
- Publication type:
- Article
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unmet supportive care needs of caregivers according to medical settings of cancer patients: a cross-sectional study.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 11, p. 9411, doi. 10.1007/s00520-022-07379-7
- By:
- Publication type:
- Article
The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3866, doi. 10.3390/curroncol28050330
- By:
- Publication type:
- Article
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920980548
- By:
- Publication type:
- Article
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 131, n. 2, p. 517, doi. 10.1007/s10549-011-1832-4
- By:
- Publication type:
- Article
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 121, n. 1, p. 121, doi. 10.1007/s10549-010-0788-0
- By:
- Publication type:
- Article
Sustainable return to work among breast cancer survivors.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 19091, doi. 10.1002/cam4.6467
- By:
- Publication type:
- Article
Change in the value of work after breast cancer: evidence from a prospective cohort.
- Published in:
- Journal of Cancer Survivorship, 2023, v. 17, n. 3, p. 694, doi. 10.1007/s11764-022-01197-w
- By:
- Publication type:
- Article
A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 886, doi. 10.1038/s41416-022-01870-y
- By:
- Publication type:
- Article
Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pregnancy outcomes in women exposed to cancer chemotherapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 12, p. 1302, doi. 10.1002/pds.4689
- By:
- Publication type:
- Article
The Quality of Life of Young Women with Nonmetastatic Breast Cancer and their Partners': Specific Needs Require Development of Specific Questionnaires for Each of them.
- Published in:
- Breast Journal, 2012, v. 18, n. 2, p. 182, doi. 10.1111/j.1524-4741.2011.01218.x
- By:
- Publication type:
- Article
Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution.
- Published in:
- Breast Journal, 2010, v. 16, n. 5, p. 464, doi. 10.1111/j.1524-4741.2010.00957.x
- By:
- Publication type:
- Article
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e867, doi. 10.1093/oncolo/oyad137
- By:
- Publication type:
- Article
Emotional processes in partners' quality of life at various stages of breast cancer pathway: a longitudinal study.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 4, p. 1085, doi. 10.1007/s11136-022-03298-6
- By:
- Publication type:
- Article
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1085, doi. 10.1002/cncr.34643
- By:
- Publication type:
- Article
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2774, doi. 10.1002/cncr.33565
- By:
- Publication type:
- Article
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1099, doi. 10.1093/jnci/djad109
- By:
- Publication type:
- Article
Cognitive change in breast cancer patients up to 2 years after diagnosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 3, p. 322, doi. 10.1093/jnci/djac240
- By:
- Publication type:
- Article
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 2, p. 329, doi. 10.1007/s12282-022-01427-0
- By:
- Publication type:
- Article